Atai Beckley Inc.
Atai Beckley Inc. (ATAI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATAI · as of Jun 8, 2026
Key Statistics
Explore Atai Beckley Inc. Data
atai stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The ATAI analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +214.96% upside from the current price of $3.81.
Competitors & Peers
atai competitorsATAI
AMLX
DNTH
ELVN
IMTX
INBXStock Performance
Full HistoryAbout Atai Beckley Inc.
Atai Beckley Inc. operates as a clinical-stage biopharmaceutical firm dedicated to the discovery, advancement, and commercialization of innovative therapeutic solutions for a variety of mental health …
what is atai beckley inc. · atai stock overview · atai beckley inc. company profile · who is atai beckley inc. ceo · atai NASDAQ · atai beckley inc. headquarters · atai beckley inc. business segments
About Stock Overview & Key Data
Atai Beckley Inc. (ATAI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 18, 2021. As of the latest trading session, ATAI stock price is $3.81, with a market capitalization of $1.4B. The stock has returned +67.32% over the past 12 months and -6.72% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Atai Beckley Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Atai Beckley Inc. reported revenue of $4.1M and net income of -$660.0M. For detailed data — including Atai Beckley Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Atai Beckley Inc. (ATAI) stock price is $3.81. The stock is traded on NASDAQ under the ticker symbol ATAI. The 52-week range is $2.00 – $6.75.